Scarica l'app Stockscreener
369.19
0.82%
2.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Amgen Inc Borsa (AMGN) Ultime notizie
BTC Capital Management Inc. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Lifted by Ameritas Advisory Services LLC - MarketBeat
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight - GuruFocus
Amgen (AMGN) Files for Automatic Mixed Securities Shelf Registra - GuruFocus
AMGEN INC SEC 10-K Report - TradingView
How to watch Amgen at Citi's 2026 virtual oncology summit - Stock Titan
Amgen wins new EU approval for Uplizna in gMG - European Pharmaceutical Review
Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN) - MSN
Here's What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Finviz
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Yahoo Finance
Amgen wins European approval to challenge argenx and UCB for autoimmune market - European Biotechnology Magazine
Amgen Inc. $AMGN Shares Sold by Savvy Advisors Inc. - MarketBeat
LSV Asset Management Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Krilogy Financial LLC Takes $1.25 Million Position in Amgen Inc. $AMGN - MarketBeat
Baader Bank Aktiengesellschaft Lowers Position in Amgen Inc. $AMGN - MarketBeat
UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen (AMGN) - simplywall.st
Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update - Yahoo Finance
AMGN: Advancing late-stage trials and expanding TSLP-targeted therapies, with major data readouts ahead - TradingView
Traders Buy Large Volume of Amgen Call Options (NASDAQ:AMGN) - MarketBeat
Amgen wins EC approval for Uplizna in gMG - The Pharma Letter
Amgen wins EC approval for Uplinza in gMG - The Pharma Letter
Varma Mutual Pension Insurance Co Buys 7,300 Shares of Amgen Inc. $AMGN - MarketBeat
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire
Leuthold Group LLC Purchases New Stake in Amgen Inc. $AMGN - MarketBeat
Stratos Wealth Partners LTD. Has $8.83 Million Stake in Amgen Inc. $AMGN - MarketBeat
Cibc World Market Inc. Grows Stake in Amgen Inc. $AMGN - MarketBeat
ABC Arbitrage SA Cuts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings - Nasdaq
Amgen (NASDAQ:AMGN) Price Target Raised to $295.00 - MarketBeat
Rhumbline Advisers Sells 6,685 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52 - simplywall.st
Prospera Financial Services Inc Sells 6,723 Shares of Amgen Inc. $AMGN - MarketBeat
Caprock Group LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Wealthfront Advisers LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Reduced by Allegheny Financial Group - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - Stock Traders Daily
AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen - Law360
Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating - marketscreener.com
Daiwa Securities Group Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
Just Two Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend - 富途牛牛
United States Biotechnology Market to hit US$ 1.5 Trillion - openPR.com
Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend - simplywall.st
Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating - marketscreener.com
The 5 Most Interesting Analyst Questions From Amgen's Q4 Earnings Call - Finviz
The 5 Most Interesting Analyst Questions From Amgen’s Q4 Earnings Call - The Globe and Mail
Alps Advisors Inc. Has $5.29 Million Stake in Amgen Inc. $AMGN - MarketBeat
Wesbanco Bank Inc. Increases Stake in Amgen Inc. $AMGN - MarketBeat
First National Trust Co Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Amgen stands by vasculitis drug Tavneos after FDA wants it pulled - ANCA Vasculitis News
When Advocacy Meets Science in the Care of People Living with gMG - Amgen
Amgen, Merck share losses contribute to Dow's 200-point drop - MSN
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Candriam S.C.A. Cuts Holdings in Amgen Inc. $AMGN - MarketBeat
ProShare Advisors LLC Sells 158,994 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen stock jumps to a 52-week high; here’s what to watch before Monday’s open - TechStock²
Amgen Reshapes Inflammation Portfolio As Investors Weigh Cash And Pipeline Shifts - Yahoo Finance
Kinsale Capital Group Inc. Has $9.65 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Bessemer Group Inc. Acquires 2,967 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen stock price hits 52-week high after Friday rally — what to watch into Monday - TechStock²
The Truth About Amgen Inc.: Is This Quiet Biotech Giant Your Next Power Move? - AD HOC NEWS
Amgen’s Stock Is Already Up 14% in 2026: Why Analysts Expect $440 - TIKR.com
Twin Capital Management Inc. Sells 5,541 Shares of Amgen Inc. $AMGN - MarketBeat
Renaissance Group LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat
SBI Securities Co. Ltd. Has $977,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - Sahm
Amgen (NASDAQ:AMGN) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists - Reuters
P/E Ratio Insights for Amgen - Benzinga
Amgen (AMGN) Sees Target Price Increase by Argus Research | AMGN Stock News - GuruFocus
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):